Showing 21-40 of 640 for: Cochrane Systematic Reviews > Cardiovascular 
- Angioplasty versus stenting for subclavian artery stenosis
Cochrane Systematic Reviews, 16-May-2014
There is insufficient evidence to guide stent usage following angioplasty in subclavian artery stenosis. This is an update of a review first published in 2011.
- Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
Cochrane Systematic Reviews, 18-Oct-2006
Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists (AIIRA) are considered to be equally effective for patients with diabetic kidney disease (DKD), but renal and not mortality outcomes have usually been considered.
- Angiotensin receptor blockers for heart failure
Cochrane Systematic Reviews, 18-Apr-2012
Chronic heart failure (HF) is a prevalent world-wide. Angiotensin receptor blockers (ARBs) are widely prescribed for chronic HF although their role is controversial.
- Antacids for preventing oesophagogastric variceal bleeding and rebleeding in cirrhotic patients
Cochrane Systematic Reviews, 3-Sep-2008
Ruptured gastroesophageal varices are the most severe and frequent cause of gastrointestinal bleeding in cirrhotic patients, leading to death in 5% to 8% of patients during the first 48 hours and oesophagogastric varices account for 60% to 80% of first bl
- Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
Cochrane Systematic Reviews, 4-Sep-2019
Atrial fibrillation is the most frequent sustained arrhythmia. Atrial fibrillation often recurs after restoration of normal sinus rhythm. Antiarrhythmic drugs have been widely used to prevent recurrence. This is an update of a review previously published
- Antibiotic prophylaxis regimens and drugs for cesarean section
Cochrane Systematic Reviews, 6-Dec-2011
Prophylactic antibiotics for cesarean section have been shown to reduce the incidence of maternal postoperative infectious morbidity. Many different antibiotic regimens have been reported to be effective.
- Antibiotic therapy for preventing infections in people with acute stroke
Cochrane Systematic Reviews, 22-Jan-2018
Stroke is the main cause of disability in high-income countries and ranks second as a cause of death worldwide. Infections occur frequently after stroke and may adversely affect outcome. Preventive antibiotic therapy in the acute phase of stroke may reduc
- Antibiotics and antiseptics for venous leg ulcers
Cochrane Systematic Reviews, 9-Jan-2014
Venous leg ulcers are a type of chronic wound affecting up to 1% of adults in developed countries at some point during their lives. Many of these wounds are colonised by bacteria or show signs of clinical infection. The presence of infection may delay ulc
- Antibiotics for brain abscesses in people with cyanotic congenital heart disease
Cochrane Systematic Reviews, 28-Mar-2013
Brain abscess is a focal, intracerebral infection that begins as a localized area of brain infection and develops into a collection of pus surrounded by a well-vascularized capsule. People with cyanotic congenital heart disease are at risk of developing b
- Antibiotics for the prophylaxis of bacterial endocarditis in dentistry
Cochrane Systematic Reviews, 3-Oct-2013
Infective endocarditis is a severe infection arising in the lining of the chambers of the heart with a high mortality rate.
- Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy
Cochrane Systematic Reviews, 6-May-2010
Thromboembolic complications are much higher in pregnancy due to procoagulant changes. Heparin does not cross the placenta and the use of unfractionated heparin (UFH) is the current established practice in prophylaxis and treatment for thromboembolism in
- Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication
Cochrane Systematic Reviews, 7-May-2014
Anticoagulant treatment for intermittent claudication might improve functional capacity and prevent acute cardiovascular complications caused by peripheral obstructive arterial disease. This is an update of the review first published in 2001.
- Anticoagulants for acute ischaemic stroke
Cochrane Systematic Reviews, 22-Oct-2021
Stroke is the third leading cause of early death worldwide. Most ischaemic strokes are caused by a blood clot blocking an artery in the brain. Patient outcomes might be improved if they are offered anticoagulants that reduce their risk of developing new b
- Anticoagulants for preventing recurrence following presumed non‐cardioembolic ischaemic stroke or transient ischaemic attack
Cochrane Systematic Reviews, 15-Apr-2009
After a first ischaemic stroke, further vascular events due to thromboembolism are common and often fatal. Anticoagulants could potentially reduce the risk of such events, but any benefits could be offset by an increased risk of fatal or disabling haemorr
- Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack
Cochrane Systematic Reviews, 6-Mar-2011
People with nonrheumatic atrial fibrillation (NRAF) who have had a transient ischaemic attack (TIA) or a minor ischaemic stroke are at high risk of recurrent stroke.
- Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter
Cochrane Systematic Reviews, 28-Oct-2008
Atrial fibrillation (AF) carries a high risk of stroke and other thromboembolic events. Appropriate use of drugs to prevent thromboembolism in patients with AF involves comparing the patient's risk of stroke to the risk of hemorrhage from medication use.
- Anticoagulants versus antiplatelet agents for acute ischaemic stroke
Cochrane Systematic Reviews, 6-Mar-2011
Antiplatelet agents produce a small, but worthwhile benefit in long-term functional outcome and survival, and have become standard treatment for acute ischaemic stroke. Anticoagulants are often used as an alternative treatment, despite evidence that they
- Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack
Cochrane Systematic Reviews, 6-Mar-2011
People with nonrheumatic atrial fibrillation (NRAF) who have had a transient ischemic attack (TIA) or minor ischemic stroke are at risk of recurrent stroke. Both warfarin and aspirin have been shown to reduce the recurrence of vascular events.
- Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism
Cochrane Systematic Reviews, 13-May-2008
Venous thromboembolism (VTE) is the term given to any thromboembolic event (blocking of a blood vessel by a blood clot) occurring in the venous system. The current treatment recommended for VTE is anticoagulation (reduction of the blood's ability to clot)
- Anticoagulation for cerebral venous sinus thrombosis
Cochrane Systematic Reviews, 10-Aug-2011
Treatment of cerebral venous sinus thrombosis with anticoagulants has been controversial. Anticoagulants may prevent new venous infarcts, neurologic deterioration and pulmonary embolism but may also promote haemorrhages.
